home / stock / nova:cc / nova:cc news

NOVA:CC News and Press, Nova Mentis Life Science Corp. From 05/13/22

Stock Information
Company Name: Nova Mentis Life Science Corp.
Stock Symbol: NOVA:CC
Market: CNQC
Menu
NOVA:CC NOVA:CC Quote NOVA:CC Short NOVA:CC News NOVA:CC Articles NOVA:CC Message Board
Get NOVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
NOVA:CC - BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), PolarityTE, Inc. (NASDAQ: PTE) Veru Inc. (NASDA...
NOVA:CC - Nova Mentis Welcomes Autism Behaviour Analyst to its Science Team

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinf...

NOVA:CC - BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma

NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Veru Inc. (NASDAQ: VERU), PharmaDrug (OTC: LMLLF) (CSE:...

NOVA:CC - Nova Mentis Psilocybin Manufacturer Receives Approved Health Canada Importation Permit

Nova Mentis Psilocybin Manufacturer Receives Approved Health Canada Importation Permit Canada NewsWire Phase 2A Microdose Clinical Study Capsules to be Manufactured VANCOUVER, BC , May 4, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA)...
NOVA:CC - Nova Mentis Sees Rapid Enrollment in Autism Study

Nova Mentis Sees Rapid Enrollment in Autism Study Canada NewsWire Databank to focus on mRNA neuroinflammatory markers and serotonin neuro-transmitters VANCOUVER, BC , April 28, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q...

NOVA:CC - BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics ...

NOVA:CC - Next Super Stocks on the Move: NEXCF, NMLSF, OGGFF, LMLLF; Driving Disruptive Innovation with Explosive Revenue Growth Potential in Biopharma, E-Commerce, Metaverse, and Plant-Based Brands

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, and online events which engage...
NOVA:CC - Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Women's Health, Autism, Glaucoma, and Cancer Therapeutics

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Brickell Biotech (NASDAQ: BBI), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therape...

NOVA:CC - Next Super Stocks on the Move: NMLSF, NEXCF, OGGFF, MKTDF; Leading Innovation in Carbon Credits, Metaverse, Plant-Based Brands, and Biopharma.

NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, which engage an estimated 12 m...

NOVA:CC - BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Clarus Therapeutics (NASDAQ...
Previous 10 Next 10